IS8559A - Lyfjasamsetning gegn sveppagerlum - Google Patents

Lyfjasamsetning gegn sveppagerlum

Info

Publication number
IS8559A
IS8559A IS8559A IS8559A IS8559A IS 8559 A IS8559 A IS 8559A IS 8559 A IS8559 A IS 8559A IS 8559 A IS8559 A IS 8559A IS 8559 A IS8559 A IS 8559A
Authority
IS
Iceland
Prior art keywords
medicinal composition
composition against
against fungal
fungal bacteria
bacteria
Prior art date
Application number
IS8559A
Other languages
English (en)
Inventor
Arora Sundershan
Sinha Neelima
Sinha Rakesh
Original Assignee
Lupin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Limited filed Critical Lupin Limited
Publication of IS8559A publication Critical patent/IS8559A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IS8559A 2004-05-12 2006-10-26 Lyfjasamsetning gegn sveppagerlum IS8559A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/844,992 US7491721B2 (en) 2004-05-12 2004-05-12 Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (en) 2004-05-12 2004-08-27 Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Publications (1)

Publication Number Publication Date
IS8559A true IS8559A (is) 2006-10-26

Family

ID=34960626

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8559A IS8559A (is) 2004-05-12 2006-10-26 Lyfjasamsetning gegn sveppagerlum

Country Status (45)

Country Link
US (1) US7491721B2 (is)
EP (1) EP1750765B1 (is)
JP (1) JP2007537242A (is)
KR (1) KR100854309B1 (is)
CN (1) CN1956732B (is)
AP (1) AP1994A (is)
AR (1) AR048948A1 (is)
AT (1) ATE373488T1 (is)
AU (1) AU2004319259A1 (is)
BR (1) BRPI0418770A (is)
CA (1) CA2566440C (is)
CR (1) CR8748A (is)
DE (1) DE602004009113T2 (is)
DK (1) DK1750765T3 (is)
DO (1) DOP2005000085A (is)
EA (1) EA009694B1 (is)
EC (1) ECSP066965A (is)
ES (1) ES2294577T3 (is)
GE (1) GEP20094805B (is)
HK (1) HK1098962A1 (is)
HN (1) HN2005000210A (is)
HR (1) HRP20070574T3 (is)
IL (1) IL178858A (is)
IS (1) IS8559A (is)
JO (1) JO2471B1 (is)
MA (1) MA28603B1 (is)
MX (1) MXPA06012984A (is)
MY (1) MY139187A (is)
NI (1) NI200600270A (is)
NO (1) NO20065725L (is)
NZ (1) NZ550892A (is)
PA (1) PA8633001A1 (is)
PE (1) PE20060353A1 (is)
PL (1) PL1750765T3 (is)
PT (1) PT1750765E (is)
RS (1) RS20060624A (is)
SA (1) SA05260130B1 (is)
SI (1) SI1750765T1 (is)
SM (1) SM200500011A (is)
SV (1) SV2006002109A (is)
TN (1) TNSN06349A1 (is)
UA (1) UA82782C2 (is)
UY (1) UY28893A1 (is)
WO (1) WO2005107809A2 (is)
ZA (1) ZA200608843B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006109323A1 (en) * 2005-04-11 2006-10-19 Lupin Limited Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) * 2008-10-02 2013-11-13 公益財団法人微生物化学研究会 抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) * 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
AU2010292148A1 (en) * 2009-09-11 2012-04-12 Vertex Pharmaceuticals Incorporated Compositions of N-benzyl-3-(4-chlorophenyl)-2- [methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-N- [3-(4-pyridyl)-1-[2-[4-pyridyl)ethy]propyl]propanamide and uses thereof
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
JP2006503837A (ja) * 2002-09-20 2006-02-02 ルピン・リミテッド 新規の抗マイコバクテリア化合物

Also Published As

Publication number Publication date
NZ550892A (en) 2009-12-24
SV2006002109A (es) 2006-04-18
EP1750765A2 (en) 2007-02-14
ATE373488T1 (de) 2007-10-15
CA2566440A1 (en) 2005-11-17
SM200500011B (it) 2005-11-16
DE602004009113T2 (de) 2008-06-19
CN1956732A (zh) 2007-05-02
US7491721B2 (en) 2009-02-17
PA8633001A1 (es) 2006-12-07
HK1098962A1 (en) 2007-08-03
NO20065725L (no) 2006-12-12
MY139187A (en) 2009-08-28
WO2005107809A3 (en) 2006-01-26
IL178858A0 (en) 2007-03-08
KR100854309B1 (ko) 2008-08-26
CN1956732B (zh) 2010-04-28
UA82782C2 (uk) 2008-05-12
WO2005107809A2 (en) 2005-11-17
PT1750765E (pt) 2007-12-31
MA28603B1 (fr) 2007-05-02
DOP2005000085A (es) 2007-01-15
ES2294577T3 (es) 2008-04-01
BRPI0418770A (pt) 2007-10-09
SA05260130B1 (ar) 2008-05-04
TNSN06349A1 (en) 2008-02-22
AR048948A1 (es) 2006-06-14
SM200500011A (it) 2005-11-16
UY28893A1 (es) 2005-12-30
KR20070007920A (ko) 2007-01-16
EP1750765B1 (en) 2007-09-19
ZA200608843B (en) 2008-07-30
WO2005107809A8 (en) 2006-05-18
MXPA06012984A (es) 2007-04-23
NI200600270A (es) 2007-12-11
AP1994A (en) 2009-04-09
RS20060624A (en) 2008-09-29
CR8748A (es) 2008-06-02
GEP20094805B (en) 2009-10-26
SI1750765T1 (sl) 2008-04-30
US20050256128A1 (en) 2005-11-17
IL178858A (en) 2010-06-16
AU2004319259A1 (en) 2005-11-17
HRP20070574T3 (en) 2008-01-31
JP2007537242A (ja) 2007-12-20
HN2005000210A (es) 2009-03-17
EA200601952A1 (ru) 2007-02-27
ECSP066965A (es) 2006-12-20
DK1750765T3 (da) 2008-01-28
EA009694B1 (ru) 2008-02-28
AP2006003807A0 (en) 2006-12-31
CA2566440C (en) 2009-08-04
JO2471B1 (en) 2009-01-20
DE602004009113D1 (de) 2007-10-31
PL1750765T3 (pl) 2008-02-29
PE20060353A1 (es) 2006-07-08

Similar Documents

Publication Publication Date Title
NO2019033I1 (no) regorafenib
RU2398586C3 (ru) Фармацевтическая композиция
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0511900A (pt) composições farmacêuticas
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
NO20053161D0 (no) Mikrobedrepende sammensetning.
BRPI0613033A2 (pt) composição oral
MA28948B1 (fr) Composition pesticide
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
DK1957073T3 (da) Lægemiddel
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
DK1793692T3 (da) Antimikrobiel sammensætning
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
DK1587478T3 (da) Farmaceutisk sammensætning
IS8559A (is) Lyfjasamsetning gegn sveppagerlum
FR2885520B1 (fr) Composition cosmetique
BRPI0614413A2 (pt) composto, e, composição farmacêutica
FR2885521B1 (fr) Composition cosmetique
ATE521769T1 (de) Beschlag
BRPI0614412A2 (pt) composto, e, composição farmacêutica
IL180316A0 (en) Quinolone-containing medicinal composition
ITBO20050375A1 (it) Riunito dentale
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
FR2871686B1 (fr) Composition anti-decoloration